| Angela D Gregg, MD | |
|
111 Deville Dr, Duncansville, PA 16635 | |
| (814) 693-0628 | |
| (814) 693-0637 |
| Full Name | Angela D Gregg |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 111 Deville Dr, Duncansville, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669450110 | NPI | - | NPPES |
| 0019665610001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD419838 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Family Hospice And Palliative Care | Altoona, PA | Hospice |
| Upmc Altoona | Altoona, PA | Hospital |
| Nason Medical Center, Llc | Roaring spring, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Altoona Regional Health Services, Inc. | 5395659312 | 214 |
News Archive
The Health Coalition on Liability and Access (HCLA) testified today before the Committee on the Judiciary of the U.S. House of Representatives in a hearing titled, "Medical Liability Reform – Cutting Costs, Spurring Investment, Creating Jobs." Stuart L. Weinstein, MD, a spokesperson for the HCLA, called on the Congress to "create a climate for patient centered care by reforming a medical liability system that continues to put everyone's health care at risk."
Young women who receive health and beauty information from their friends and through social media may be more likely to ignore the risks of indoor tanning, according to a team of researchers.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.
› Verified 9 days ago
| Entity Name | Upmc Altoona Regional Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396724217 PECOS PAC ID: 5395659312 Enrollment ID: O20040312000257 |
News Archive
The Health Coalition on Liability and Access (HCLA) testified today before the Committee on the Judiciary of the U.S. House of Representatives in a hearing titled, "Medical Liability Reform – Cutting Costs, Spurring Investment, Creating Jobs." Stuart L. Weinstein, MD, a spokesperson for the HCLA, called on the Congress to "create a climate for patient centered care by reforming a medical liability system that continues to put everyone's health care at risk."
Young women who receive health and beauty information from their friends and through social media may be more likely to ignore the risks of indoor tanning, according to a team of researchers.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela D Gregg, MD 1414 9th Ave, Station Medical Center, Altoona, PA 16602-2454 Ph: (814) 946-1655 | Angela D Gregg, MD 111 Deville Dr, Duncansville, PA 16635 Ph: (814) 693-0628 |
News Archive
The Health Coalition on Liability and Access (HCLA) testified today before the Committee on the Judiciary of the U.S. House of Representatives in a hearing titled, "Medical Liability Reform – Cutting Costs, Spurring Investment, Creating Jobs." Stuart L. Weinstein, MD, a spokesperson for the HCLA, called on the Congress to "create a climate for patient centered care by reforming a medical liability system that continues to put everyone's health care at risk."
Young women who receive health and beauty information from their friends and through social media may be more likely to ignore the risks of indoor tanning, according to a team of researchers.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.
› Verified 9 days ago
Dr. David Landon Burwell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 764 Plz, Duncansville, PA 16635 Phone: 814-695-3305 | |
Vicki M Sommer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1125 Old Rte 220 N, Duncansville, PA 16635 Phone: 814-693-0300 Fax: 814-693-0400 |